Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apyrase | 162 | 2023 | 364 | 21.830 |
Why?
|
Antigens, CD | 151 | 2023 | 4026 | 11.500 |
Why?
|
Adenosine Triphosphatases | 63 | 2020 | 839 | 5.740 |
Why?
|
5'-Nucleotidase | 30 | 2024 | 160 | 5.490 |
Why?
|
Transplantation, Heterologous | 78 | 2021 | 2382 | 4.240 |
Why?
|
Adenosine | 42 | 2024 | 825 | 3.480 |
Why?
|
Adenosine Triphosphate | 59 | 2023 | 2025 | 3.270 |
Why?
|
Receptors, Purinergic P2 | 25 | 2020 | 153 | 2.680 |
Why?
|
Receptors, Purinergic | 11 | 2021 | 66 | 2.570 |
Why?
|
Endothelium, Vascular | 47 | 2023 | 4456 | 1.940 |
Why?
|
Liver Regeneration | 12 | 2020 | 210 | 1.940 |
Why?
|
Th17 Cells | 14 | 2023 | 766 | 1.880 |
Why?
|
Platelet Aggregation | 26 | 2021 | 798 | 1.830 |
Why?
|
Graft Rejection | 50 | 2020 | 4397 | 1.750 |
Why?
|
Reperfusion Injury | 19 | 2022 | 1026 | 1.670 |
Why?
|
Liver | 35 | 2021 | 7474 | 1.670 |
Why?
|
Platelet Activation | 18 | 2020 | 673 | 1.510 |
Why?
|
Crohn Disease | 14 | 2022 | 2303 | 1.380 |
Why?
|
Animals | 306 | 2024 | 168757 | 1.380 |
Why?
|
Swine | 71 | 2023 | 5917 | 1.350 |
Why?
|
Pyrophosphatases | 9 | 2021 | 137 | 1.340 |
Why?
|
Receptors, Purinergic P1 | 8 | 2020 | 109 | 1.330 |
Why?
|
Acute Lung Injury | 5 | 2018 | 380 | 1.270 |
Why?
|
Signal Transduction | 61 | 2023 | 23403 | 1.240 |
Why?
|
Adenosine Diphosphate | 21 | 2019 | 425 | 1.240 |
Why?
|
Hepatitis, Autoimmune | 8 | 2023 | 141 | 1.190 |
Why?
|
Mice, Inbred C57BL | 85 | 2022 | 21827 | 1.160 |
Why?
|
Immune Tolerance | 14 | 2020 | 2258 | 1.160 |
Why?
|
Blood Platelets | 21 | 2020 | 2508 | 1.150 |
Why?
|
T-Lymphocytes, Regulatory | 22 | 2022 | 2988 | 1.150 |
Why?
|
Papio | 31 | 2014 | 656 | 1.100 |
Why?
|
Inflammation | 32 | 2023 | 10638 | 1.100 |
Why?
|
Purine Nucleotides | 3 | 2021 | 28 | 1.100 |
Why?
|
Hyperoxia | 4 | 2018 | 262 | 1.100 |
Why?
|
Blood Coagulation Disorders | 8 | 2015 | 337 | 1.090 |
Why?
|
Receptors, Purinergic P2X7 | 11 | 2020 | 85 | 1.090 |
Why?
|
Mice | 155 | 2024 | 81183 | 1.090 |
Why?
|
Receptors, Aryl Hydrocarbon | 7 | 2023 | 209 | 1.040 |
Why?
|
Cell-Derived Microparticles | 5 | 2020 | 168 | 1.020 |
Why?
|
Mice, Knockout | 68 | 2024 | 14557 | 1.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 82 | 1.010 |
Why?
|
Purines | 5 | 2022 | 594 | 0.990 |
Why?
|
Thrombosis | 23 | 2016 | 2968 | 0.980 |
Why?
|
Inflammatory Bowel Diseases | 8 | 2021 | 2425 | 0.980 |
Why?
|
Endothelial Cells | 18 | 2023 | 3479 | 0.950 |
Why?
|
Colitis | 8 | 2022 | 1170 | 0.930 |
Why?
|
Platelet Aggregation Inhibitors | 11 | 2020 | 3068 | 0.840 |
Why?
|
Graft Survival | 32 | 2015 | 3737 | 0.840 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2023 | 4479 | 0.840 |
Why?
|
Killer Cells, Natural | 13 | 2022 | 2133 | 0.830 |
Why?
|
Hepatectomy | 10 | 2020 | 550 | 0.810 |
Why?
|
Nucleotides | 8 | 2012 | 464 | 0.790 |
Why?
|
Natural Killer T-Cells | 2 | 2015 | 316 | 0.770 |
Why?
|
Mucous Membrane | 3 | 2018 | 673 | 0.750 |
Why?
|
Colon | 10 | 2023 | 1772 | 0.740 |
Why?
|
Immunity | 3 | 2020 | 1012 | 0.740 |
Why?
|
Liver Cirrhosis | 8 | 2019 | 1863 | 0.740 |
Why?
|
Heart Transplantation | 25 | 2014 | 3110 | 0.740 |
Why?
|
Cholangitis, Sclerosing | 2 | 2019 | 159 | 0.720 |
Why?
|
Liver Transplantation | 13 | 2021 | 2119 | 0.720 |
Why?
|
Blood Coagulation | 13 | 2019 | 1127 | 0.710 |
Why?
|
Phosphoric Diester Hydrolases | 4 | 2016 | 197 | 0.700 |
Why?
|
Animals, Genetically Modified | 20 | 2021 | 1549 | 0.680 |
Why?
|
Leukocytes, Mononuclear | 6 | 2022 | 1836 | 0.660 |
Why?
|
GPI-Linked Proteins | 9 | 2021 | 434 | 0.650 |
Why?
|
Carcinoma, Hepatocellular | 9 | 2019 | 2214 | 0.640 |
Why?
|
Liver Neoplasms | 14 | 2019 | 4253 | 0.640 |
Why?
|
Macrophages | 20 | 2020 | 5655 | 0.640 |
Why?
|
Gene Knockout Techniques | 6 | 2017 | 809 | 0.640 |
Why?
|
Galactosyltransferases | 13 | 2013 | 263 | 0.640 |
Why?
|
Protein Engineering | 3 | 2020 | 540 | 0.620 |
Why?
|
Cell Movement | 13 | 2018 | 5217 | 0.610 |
Why?
|
Blood Vessels | 4 | 2021 | 1125 | 0.590 |
Why?
|
Melanoma, Experimental | 5 | 2020 | 561 | 0.580 |
Why?
|
von Willebrand Factor | 9 | 2012 | 669 | 0.580 |
Why?
|
Myocardial Reperfusion Injury | 8 | 2014 | 476 | 0.570 |
Why?
|
Gene Deletion | 10 | 2021 | 2751 | 0.570 |
Why?
|
Receptor, Adenosine A2B | 5 | 2022 | 33 | 0.560 |
Why?
|
Hemostatic Disorders | 1 | 2015 | 3 | 0.540 |
Why?
|
Cell Proliferation | 25 | 2020 | 10481 | 0.540 |
Why?
|
Sepsis | 7 | 2021 | 2593 | 0.540 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2015 | 93 | 0.530 |
Why?
|
Kidney Diseases | 5 | 2020 | 2149 | 0.530 |
Why?
|
CD4-Positive T-Lymphocytes | 9 | 2018 | 4386 | 0.530 |
Why?
|
Lung | 7 | 2021 | 9856 | 0.520 |
Why?
|
Anti-Inflammatory Agents | 5 | 2021 | 1790 | 0.520 |
Why?
|
Kwashiorkor | 1 | 2014 | 24 | 0.510 |
Why?
|
Cells, Cultured | 46 | 2023 | 19229 | 0.510 |
Why?
|
Kidney | 17 | 2021 | 7186 | 0.510 |
Why?
|
Humans | 228 | 2023 | 744343 | 0.500 |
Why?
|
Liver Neoplasms, Experimental | 2 | 2013 | 191 | 0.500 |
Why?
|
Diabetic Nephropathies | 3 | 2020 | 984 | 0.490 |
Why?
|
Bilirubin | 3 | 2022 | 425 | 0.490 |
Why?
|
Portal Vein | 3 | 2016 | 437 | 0.480 |
Why?
|
Oxygen | 4 | 2023 | 4189 | 0.480 |
Why?
|
Hematopoietic Stem Cells | 6 | 2019 | 3386 | 0.480 |
Why?
|
Lysophospholipids | 2 | 2015 | 331 | 0.480 |
Why?
|
Colitis, Ulcerative | 7 | 2020 | 1912 | 0.470 |
Why?
|
Hydrolysis | 10 | 2021 | 682 | 0.460 |
Why?
|
Kidney Transplantation | 14 | 2020 | 4251 | 0.460 |
Why?
|
Cytokines | 20 | 2022 | 7322 | 0.460 |
Why?
|
Thromboplastin | 9 | 2017 | 291 | 0.460 |
Why?
|
Calcinosis | 3 | 2023 | 1499 | 0.450 |
Why?
|
Glycoproteins | 4 | 2016 | 2263 | 0.450 |
Why?
|
Up-Regulation | 11 | 2020 | 4217 | 0.450 |
Why?
|
Urinary Bladder | 6 | 2024 | 1172 | 0.440 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2021 | 990 | 0.430 |
Why?
|
Adenosine Deaminase | 4 | 2021 | 241 | 0.430 |
Why?
|
Flow Cytometry | 18 | 2024 | 5974 | 0.430 |
Why?
|
Multienzyme Complexes | 2 | 2015 | 686 | 0.430 |
Why?
|
Disease Models, Animal | 35 | 2023 | 18029 | 0.430 |
Why?
|
Autoimmune Diseases | 6 | 2019 | 2133 | 0.430 |
Why?
|
Cochlea | 6 | 2010 | 828 | 0.420 |
Why?
|
Peptides | 10 | 2016 | 4409 | 0.420 |
Why?
|
Disaccharides | 6 | 2004 | 171 | 0.420 |
Why?
|
T-Lymphocyte Subsets | 6 | 2021 | 1838 | 0.420 |
Why?
|
Transplantation Chimera | 5 | 2014 | 612 | 0.410 |
Why?
|
Forkhead Transcription Factors | 8 | 2022 | 1613 | 0.410 |
Why?
|
Transfection | 18 | 2017 | 5892 | 0.400 |
Why?
|
Hepatocytes | 8 | 2020 | 1211 | 0.400 |
Why?
|
Dextran Sulfate | 6 | 2022 | 236 | 0.400 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1438 | 0.390 |
Why?
|
Autocrine Communication | 4 | 2021 | 171 | 0.390 |
Why?
|
Atherosclerosis | 3 | 2023 | 3445 | 0.390 |
Why?
|
Blotting, Western | 16 | 2016 | 5179 | 0.390 |
Why?
|
Antibodies, Heterophile | 6 | 2004 | 126 | 0.390 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2021 | 5442 | 0.390 |
Why?
|
Liver Diseases | 3 | 2014 | 1253 | 0.380 |
Why?
|
Receptor, Adenosine A2A | 6 | 2016 | 124 | 0.370 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2219 | 0.370 |
Why?
|
Disseminated Intravascular Coagulation | 5 | 2012 | 188 | 0.370 |
Why?
|
E-Selectin | 7 | 2002 | 579 | 0.370 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2024 | 1821 | 0.350 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2020 | 1114 | 0.350 |
Why?
|
Interferon-gamma | 3 | 2022 | 3206 | 0.350 |
Why?
|
Alkaline Phosphatase | 6 | 2024 | 865 | 0.350 |
Why?
|
Sequence Deletion | 3 | 2009 | 1526 | 0.340 |
Why?
|
Splanchnic Circulation | 1 | 2009 | 110 | 0.340 |
Why?
|
COS Cells | 12 | 2018 | 1161 | 0.340 |
Why?
|
Kupffer Cells | 3 | 2021 | 142 | 0.330 |
Why?
|
Male | 115 | 2023 | 350118 | 0.330 |
Why?
|
Umbilical Veins | 7 | 2005 | 433 | 0.330 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 627 | 0.330 |
Why?
|
Concanavalin A | 1 | 2008 | 191 | 0.330 |
Why?
|
Bone Marrow Cells | 5 | 2021 | 2513 | 0.330 |
Why?
|
Microcirculation | 8 | 2009 | 1286 | 0.320 |
Why?
|
Antibodies, Monoclonal | 9 | 2020 | 9274 | 0.320 |
Why?
|
Receptors, Purinergic P2X4 | 2 | 2018 | 22 | 0.320 |
Why?
|
Fatty Liver | 2 | 2022 | 727 | 0.320 |
Why?
|
Extracellular Space | 2 | 2011 | 594 | 0.320 |
Why?
|
Mitogens | 1 | 2008 | 232 | 0.320 |
Why?
|
Gene Expression Regulation, Enzymologic | 6 | 2020 | 1213 | 0.320 |
Why?
|
Rats | 34 | 2024 | 24260 | 0.320 |
Why?
|
Neuroglia | 5 | 2022 | 927 | 0.320 |
Why?
|
Antibodies | 8 | 2014 | 2460 | 0.310 |
Why?
|
Swine, Miniature | 10 | 2012 | 961 | 0.310 |
Why?
|
Thrombocytopenia | 9 | 2015 | 1179 | 0.310 |
Why?
|
Immunohistochemistry | 26 | 2018 | 11366 | 0.310 |
Why?
|
Apoptosis | 17 | 2022 | 9727 | 0.310 |
Why?
|
Interleukin-17 | 6 | 2022 | 899 | 0.300 |
Why?
|
Acetaminophen | 3 | 2020 | 545 | 0.300 |
Why?
|
Immunologic Memory | 2 | 2021 | 1348 | 0.300 |
Why?
|
RNA, Messenger | 24 | 2016 | 13033 | 0.300 |
Why?
|
T-Lymphocytes | 10 | 2021 | 10180 | 0.290 |
Why?
|
Hypertension, Portal | 1 | 2009 | 220 | 0.290 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 4751 | 0.290 |
Why?
|
Plasma | 2 | 2020 | 575 | 0.290 |
Why?
|
Receptors, Purinergic P2Y12 | 2 | 2019 | 132 | 0.280 |
Why?
|
ran GTP-Binding Protein | 1 | 2006 | 54 | 0.280 |
Why?
|
Bile Duct Neoplasms | 3 | 2016 | 567 | 0.280 |
Why?
|
Vascular Diseases | 3 | 2022 | 1161 | 0.280 |
Why?
|
Aurintricarboxylic Acid | 3 | 2012 | 11 | 0.280 |
Why?
|
Necrosis | 5 | 2020 | 1643 | 0.280 |
Why?
|
Stem Cell Niche | 3 | 2021 | 346 | 0.280 |
Why?
|
Intestinal Mucosa | 6 | 2022 | 3036 | 0.280 |
Why?
|
NF-kappa B | 9 | 2017 | 2499 | 0.280 |
Why?
|
Carbon Monoxide | 4 | 2018 | 531 | 0.280 |
Why?
|
Platelet Membrane Glycoproteins | 3 | 2003 | 293 | 0.280 |
Why?
|
Pancreas | 3 | 2008 | 1686 | 0.270 |
Why?
|
Inflammation Mediators | 4 | 2017 | 1889 | 0.270 |
Why?
|
Gastric Bypass | 1 | 2014 | 812 | 0.270 |
Why?
|
Cell Membrane | 6 | 2018 | 3748 | 0.270 |
Why?
|
Receptors, Purinergic P2Y1 | 5 | 2021 | 40 | 0.270 |
Why?
|
Neoplasms | 9 | 2022 | 21683 | 0.270 |
Why?
|
Serum | 2 | 2017 | 214 | 0.270 |
Why?
|
Adenine Nucleotides | 3 | 2020 | 121 | 0.260 |
Why?
|
Fibrosis | 7 | 2023 | 2029 | 0.260 |
Why?
|
Capillary Permeability | 1 | 2009 | 798 | 0.260 |
Why?
|
Neutrophils | 8 | 2022 | 3719 | 0.260 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2012 | 1038 | 0.260 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2013 | 1116 | 0.260 |
Why?
|
Kynurenine | 3 | 2023 | 139 | 0.260 |
Why?
|
Rats, Inbred Lew | 11 | 2005 | 1162 | 0.250 |
Why?
|
Lipoproteins, VLDL | 2 | 2016 | 201 | 0.250 |
Why?
|
Paracrine Communication | 4 | 2021 | 277 | 0.250 |
Why?
|
Scleroderma, Systemic | 2 | 2022 | 323 | 0.250 |
Why?
|
Adenosine Monophosphate | 8 | 2020 | 275 | 0.250 |
Why?
|
Thrombomodulin | 2 | 2011 | 102 | 0.250 |
Why?
|
Immunosuppressive Agents | 5 | 2015 | 4149 | 0.250 |
Why?
|
Neovascularization, Pathologic | 2 | 2022 | 2635 | 0.250 |
Why?
|
Enteric Nervous System | 2 | 2017 | 189 | 0.250 |
Why?
|
STAT3 Transcription Factor | 5 | 2019 | 873 | 0.250 |
Why?
|
Complement Activation | 7 | 2005 | 453 | 0.240 |
Why?
|
Arterial Occlusive Diseases | 2 | 2016 | 793 | 0.240 |
Why?
|
Leukocytes | 6 | 2024 | 2043 | 0.240 |
Why?
|
Monocytes | 10 | 2021 | 2596 | 0.240 |
Why?
|
Hemolysis | 2 | 2023 | 420 | 0.240 |
Why?
|
Caveolae | 1 | 2004 | 57 | 0.240 |
Why?
|
Hepatitis B virus | 3 | 2019 | 513 | 0.240 |
Why?
|
Bone Marrow Transplantation | 6 | 2021 | 2765 | 0.240 |
Why?
|
Pancreatic Diseases | 1 | 2006 | 350 | 0.240 |
Why?
|
Nucleotidases | 4 | 2012 | 31 | 0.240 |
Why?
|
Gastrointestinal Agents | 3 | 2021 | 494 | 0.240 |
Why?
|
Cardiopulmonary Bypass | 2 | 2020 | 1066 | 0.240 |
Why?
|
Uridine Triphosphate | 4 | 2015 | 26 | 0.230 |
Why?
|
Microglia | 4 | 2020 | 1266 | 0.230 |
Why?
|
P-Selectin | 3 | 2020 | 600 | 0.230 |
Why?
|
Mitochondria | 6 | 2022 | 3520 | 0.230 |
Why?
|
Neovascularization, Physiologic | 2 | 2020 | 1351 | 0.230 |
Why?
|
Aorta | 10 | 2014 | 2061 | 0.230 |
Why?
|
Prosencephalon | 2 | 2016 | 303 | 0.230 |
Why?
|
Heart Arrest | 2 | 2024 | 1470 | 0.230 |
Why?
|
Pancreatitis | 2 | 2007 | 1092 | 0.230 |
Why?
|
Vitamin D | 4 | 2020 | 3223 | 0.230 |
Why?
|
Transplantation | 1 | 2005 | 217 | 0.230 |
Why?
|
Substrate Specificity | 5 | 2020 | 1801 | 0.220 |
Why?
|
Immunodominant Epitopes | 1 | 2004 | 267 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2013 | 3508 | 0.220 |
Why?
|
Blood Proteins | 1 | 2008 | 1124 | 0.220 |
Why?
|
Kinetics | 7 | 2020 | 6473 | 0.220 |
Why?
|
Drug Discovery | 2 | 2020 | 1058 | 0.220 |
Why?
|
Integrins | 1 | 2007 | 846 | 0.220 |
Why?
|
Oxidative Stress | 7 | 2021 | 3086 | 0.220 |
Why?
|
Female | 78 | 2021 | 380194 | 0.220 |
Why?
|
Hepatocyte Growth Factor | 3 | 2020 | 270 | 0.220 |
Why?
|
HEK293 Cells | 4 | 2020 | 4204 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 12 | 2022 | 4420 | 0.210 |
Why?
|
Intestines | 6 | 2020 | 1924 | 0.210 |
Why?
|
Colonic Neoplasms | 3 | 2012 | 2541 | 0.210 |
Why?
|
Caveolin 1 | 2 | 2020 | 263 | 0.210 |
Why?
|
Transplantation Conditioning | 8 | 2021 | 1598 | 0.210 |
Why?
|
Rodentia | 1 | 2024 | 261 | 0.210 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1676 | 0.210 |
Why?
|
MicroRNAs | 5 | 2023 | 3752 | 0.210 |
Why?
|
Thrombin | 4 | 2003 | 598 | 0.210 |
Why?
|
Transforming Growth Factor beta1 | 3 | 2022 | 644 | 0.200 |
Why?
|
Fibrinolytic Agents | 5 | 2017 | 2158 | 0.200 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 818 | 0.200 |
Why?
|
Myocardium | 10 | 2022 | 4776 | 0.200 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2009 | 1130 | 0.200 |
Why?
|
Immunomodulation | 3 | 2020 | 541 | 0.200 |
Why?
|
Peritonitis | 1 | 2004 | 365 | 0.200 |
Why?
|
Adenoviridae | 4 | 2011 | 1099 | 0.200 |
Why?
|
Mice, Transgenic | 15 | 2019 | 9734 | 0.200 |
Why?
|
Polysaccharides, Bacterial | 2 | 2014 | 578 | 0.200 |
Why?
|
Immunophenotyping | 6 | 2020 | 1880 | 0.200 |
Why?
|
Vasculitis | 2 | 2005 | 519 | 0.200 |
Why?
|
Heme | 1 | 2023 | 307 | 0.200 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2012 | 227 | 0.190 |
Why?
|
Lymphocytes | 2 | 2020 | 2617 | 0.190 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 390 | 0.190 |
Why?
|
Benzyl Alcohols | 1 | 2020 | 29 | 0.190 |
Why?
|
Aortic Valve Stenosis | 2 | 2023 | 1965 | 0.190 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 5 | 2005 | 141 | 0.190 |
Why?
|
Cell Communication | 5 | 2020 | 1621 | 0.190 |
Why?
|
Acute Kidney Injury | 3 | 2021 | 1972 | 0.190 |
Why?
|
Models, Animal | 5 | 2014 | 2171 | 0.180 |
Why?
|
RNA, Antisense | 1 | 2020 | 138 | 0.180 |
Why?
|
Health Status | 1 | 2013 | 4034 | 0.180 |
Why?
|
Mice, Inbred Strains | 5 | 2006 | 1827 | 0.180 |
Why?
|
Muscle Contraction | 5 | 2019 | 1240 | 0.180 |
Why?
|
Anticoagulants | 4 | 2012 | 4599 | 0.180 |
Why?
|
Mice, Inbred BALB C | 9 | 2021 | 6386 | 0.180 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3129 | 0.180 |
Why?
|
Liver Function Tests | 4 | 2015 | 528 | 0.180 |
Why?
|
Oxalates | 1 | 2020 | 105 | 0.180 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4328 | 0.180 |
Why?
|
Immunization | 3 | 2016 | 1256 | 0.180 |
Why?
|
Basal Metabolism | 1 | 2021 | 168 | 0.180 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2022 | 157 | 0.180 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1632 | 0.180 |
Why?
|
Inflammasomes | 3 | 2020 | 495 | 0.180 |
Why?
|
Guinea Pigs | 8 | 2000 | 1386 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 7 | 2017 | 3870 | 0.170 |
Why?
|
Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.170 |
Why?
|
Myocardial Infarction | 8 | 2022 | 11727 | 0.170 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 109 | 0.170 |
Why?
|
Insulin Resistance | 2 | 2015 | 3864 | 0.170 |
Why?
|
Alanine Transaminase | 4 | 2020 | 592 | 0.170 |
Why?
|
Lymphocyte Activation | 7 | 2018 | 5524 | 0.170 |
Why?
|
Protein C | 1 | 2019 | 138 | 0.170 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2012 | 641 | 0.170 |
Why?
|
Palmitic Acid | 1 | 2000 | 154 | 0.170 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2018 | 107 | 0.170 |
Why?
|
Mice, Mutant Strains | 6 | 2020 | 1866 | 0.170 |
Why?
|
Neuropeptide Y | 1 | 2020 | 200 | 0.170 |
Why?
|
Autophagy | 3 | 2020 | 1300 | 0.170 |
Why?
|
Keratin-18 | 2 | 2016 | 39 | 0.170 |
Why?
|
Carcinoma 256, Walker | 2 | 2010 | 39 | 0.170 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2016 | 2455 | 0.170 |
Why?
|
Recombinant Proteins | 10 | 2017 | 6622 | 0.170 |
Why?
|
Astrocytes | 2 | 2006 | 1270 | 0.170 |
Why?
|
Gene Expression Regulation | 10 | 2013 | 12072 | 0.170 |
Why?
|
Interleukin-8 | 4 | 2016 | 690 | 0.170 |
Why?
|
Dendritic Cells | 4 | 2015 | 2725 | 0.160 |
Why?
|
Metalloendopeptidases | 1 | 2000 | 396 | 0.160 |
Why?
|
Hepatitis, Viral, Human | 1 | 2019 | 138 | 0.160 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 198 | 0.160 |
Why?
|
Adoptive Transfer | 3 | 2022 | 844 | 0.160 |
Why?
|
Graft vs Host Disease | 2 | 2021 | 2957 | 0.160 |
Why?
|
Gene Expression | 12 | 2016 | 7799 | 0.160 |
Why?
|
Blood Transfusion | 2 | 2023 | 1301 | 0.160 |
Why?
|
Receptors, Purinergic P2Y2 | 4 | 2006 | 18 | 0.160 |
Why?
|
Epithelial Cells | 3 | 2022 | 3690 | 0.160 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2018 | 56 | 0.160 |
Why?
|
Lipoproteins | 2 | 2008 | 878 | 0.160 |
Why?
|
Ischemic Preconditioning | 2 | 2010 | 92 | 0.160 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2569 | 0.160 |
Why?
|
Databases, Nucleic Acid | 1 | 2019 | 211 | 0.160 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3586 | 0.160 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2018 | 367 | 0.160 |
Why?
|
Factor Xa | 2 | 2008 | 162 | 0.160 |
Why?
|
Feedback, Physiological | 1 | 2020 | 479 | 0.150 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2020 | 362 | 0.150 |
Why?
|
Glycosylation | 4 | 2017 | 1126 | 0.150 |
Why?
|
Chemotaxis | 2 | 2013 | 607 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 4 | 2020 | 3772 | 0.150 |
Why?
|
Virus Integration | 2 | 2017 | 299 | 0.150 |
Why?
|
Hemodynamics | 4 | 2023 | 4199 | 0.150 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2017 | 69 | 0.150 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5256 | 0.150 |
Why?
|
Period Circadian Proteins | 1 | 2018 | 102 | 0.150 |
Why?
|
Ultraviolet Rays | 2 | 2021 | 1060 | 0.150 |
Why?
|
Rats, Wistar | 10 | 2020 | 1901 | 0.150 |
Why?
|
Cell Line, Tumor | 14 | 2021 | 16689 | 0.150 |
Why?
|
Lung Transplantation | 3 | 2013 | 1153 | 0.150 |
Why?
|
Prothrombin | 1 | 1997 | 185 | 0.150 |
Why?
|
Catalysis | 4 | 2008 | 761 | 0.150 |
Why?
|
Uridine Diphosphate | 4 | 2013 | 32 | 0.150 |
Why?
|
Sus scrofa | 6 | 2017 | 437 | 0.150 |
Why?
|
Immunity, Innate | 5 | 2022 | 2958 | 0.150 |
Why?
|
Image Cytometry | 1 | 2017 | 54 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2020 | 2557 | 0.150 |
Why?
|
Fibroblasts | 7 | 2022 | 4161 | 0.150 |
Why?
|
Time Factors | 20 | 2020 | 40075 | 0.150 |
Why?
|
Cardiotonic Agents | 1 | 2020 | 535 | 0.150 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 612 | 0.140 |
Why?
|
Gallbladder Neoplasms | 1 | 2018 | 183 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2938 | 0.140 |
Why?
|
Immunity, Cellular | 3 | 2020 | 1607 | 0.140 |
Why?
|
Interleukin-6 | 7 | 2020 | 3200 | 0.140 |
Why?
|
Bacteroides fragilis | 2 | 2014 | 212 | 0.140 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 383 | 0.140 |
Why?
|
Ischemic Preconditioning, Myocardial | 2 | 2007 | 67 | 0.140 |
Why?
|
Calcium Signaling | 3 | 2017 | 721 | 0.140 |
Why?
|
Nucleoside-Triphosphatase | 4 | 2004 | 19 | 0.140 |
Why?
|
Ammonia | 1 | 2017 | 239 | 0.140 |
Why?
|
Hepatic Duct, Common | 1 | 2016 | 50 | 0.140 |
Why?
|
Neural Inhibition | 1 | 2020 | 602 | 0.140 |
Why?
|
Neuromuscular Junction | 2 | 2017 | 398 | 0.140 |
Why?
|
DNA Primers | 6 | 2012 | 2892 | 0.140 |
Why?
|
Plant Lectins | 3 | 2004 | 104 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2017 | 1504 | 0.140 |
Why?
|
I-kappa B Proteins | 1 | 1997 | 225 | 0.140 |
Why?
|
L-Selectin | 1 | 2016 | 213 | 0.140 |
Why?
|
Interleukin-1 | 1 | 2000 | 1263 | 0.140 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 30 | 0.140 |
Why?
|
Receptors, Complement | 3 | 2007 | 264 | 0.140 |
Why?
|
Acute Disease | 10 | 2011 | 7149 | 0.140 |
Why?
|
Adult | 34 | 2021 | 214055 | 0.140 |
Why?
|
Purinergic Agents | 1 | 2015 | 5 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2538 | 0.140 |
Why?
|
RNA Virus Infections | 1 | 2015 | 17 | 0.140 |
Why?
|
Angiopoietin-1 | 1 | 2016 | 114 | 0.140 |
Why?
|
Antiphospholipid Syndrome | 1 | 2017 | 173 | 0.140 |
Why?
|
Gastrointestinal Motility | 1 | 2017 | 225 | 0.130 |
Why?
|
Intestine, Small | 2 | 2017 | 1241 | 0.130 |
Why?
|
Sodium Chloride Symporters | 1 | 2015 | 11 | 0.130 |
Why?
|
Homeostasis | 3 | 2021 | 3340 | 0.130 |
Why?
|
Receptor, TIE-2 | 1 | 2016 | 178 | 0.130 |
Why?
|
Cyclophosphamide | 1 | 2001 | 2242 | 0.130 |
Why?
|
Lysophosphatidylcholines | 1 | 2015 | 81 | 0.130 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2016 | 77 | 0.130 |
Why?
|
Transplantation Immunology | 4 | 2013 | 546 | 0.130 |
Why?
|
Eosinophils | 1 | 2020 | 955 | 0.130 |
Why?
|
Natriuresis | 1 | 2015 | 124 | 0.130 |
Why?
|
Immunoconjugates | 2 | 2014 | 901 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 2077 | 0.130 |
Why?
|
Endopeptidases | 1 | 1999 | 772 | 0.130 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2023 | 980 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2004 | 1401 | 0.130 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 173 | 0.130 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2015 | 60 | 0.130 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2016 | 104 | 0.130 |
Why?
|
Placenta | 1 | 2004 | 1698 | 0.130 |
Why?
|
Base Sequence | 9 | 2011 | 12797 | 0.130 |
Why?
|
Pancreatic Function Tests | 1 | 2014 | 69 | 0.130 |
Why?
|
Peptide Fragments | 3 | 2020 | 5097 | 0.120 |
Why?
|
Cell Adhesion | 4 | 2020 | 3144 | 0.120 |
Why?
|
Toll-Like Receptor 2 | 2 | 2014 | 354 | 0.120 |
Why?
|
Encephalomyelitis | 1 | 2014 | 34 | 0.120 |
Why?
|
Erythrocytes | 2 | 2023 | 2455 | 0.120 |
Why?
|
Complement System Proteins | 6 | 2023 | 795 | 0.120 |
Why?
|
Lectins | 4 | 2013 | 513 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
Coffee | 1 | 2019 | 578 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4665 | 0.120 |
Why?
|
Heme Oxygenase (Decyclizing) | 3 | 2005 | 171 | 0.120 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2014 | 91 | 0.120 |
Why?
|
Middle Aged | 29 | 2021 | 213383 | 0.120 |
Why?
|
Polymerase Chain Reaction | 5 | 2012 | 6171 | 0.120 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 294 | 0.120 |
Why?
|
Cell Count | 2 | 2015 | 1856 | 0.120 |
Why?
|
Transplantation, Homologous | 7 | 2021 | 4776 | 0.120 |
Why?
|
Hepatitis B | 2 | 2017 | 695 | 0.120 |
Why?
|
Embolization, Therapeutic | 2 | 2016 | 1392 | 0.120 |
Why?
|
Malabsorption Syndromes | 1 | 2014 | 135 | 0.120 |
Why?
|
Smoke | 1 | 2015 | 227 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15519 | 0.120 |
Why?
|
Taste Buds | 1 | 2013 | 25 | 0.120 |
Why?
|
Chromatography, Gel | 1 | 2014 | 668 | 0.120 |
Why?
|
Polysaccharides | 1 | 2000 | 1053 | 0.120 |
Why?
|
Coronary Vessels | 3 | 2012 | 3107 | 0.120 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 3462 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 2104 | 0.120 |
Why?
|
Myeloid Cells | 2 | 2020 | 810 | 0.120 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2012 | 310 | 0.120 |
Why?
|
Elapid Venoms | 4 | 1996 | 40 | 0.120 |
Why?
|
Bone Marrow | 2 | 2021 | 2948 | 0.120 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1878 | 0.110 |
Why?
|
Biological Transport | 2 | 2017 | 2118 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2013 | 2109 | 0.110 |
Why?
|
Acid Anhydride Hydrolases | 3 | 2001 | 72 | 0.110 |
Why?
|
Renal Circulation | 3 | 2008 | 333 | 0.110 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2020 | 2208 | 0.110 |
Why?
|
Receptors, Purinergic P2X1 | 1 | 2013 | 8 | 0.110 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4262 | 0.110 |
Why?
|
Organogenesis | 1 | 2014 | 222 | 0.110 |
Why?
|
Immunologic Factors | 3 | 2020 | 1580 | 0.110 |
Why?
|
Antithrombins | 1 | 1996 | 304 | 0.110 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2013 | 114 | 0.110 |
Why?
|
Molecular Sequence Data | 10 | 2011 | 18111 | 0.110 |
Why?
|
Hepatitis | 1 | 2015 | 227 | 0.110 |
Why?
|
Enzyme Inhibitors | 5 | 2018 | 3798 | 0.110 |
Why?
|
Cell Transplantation | 1 | 1995 | 477 | 0.110 |
Why?
|
Noise | 2 | 2006 | 279 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1621 | 0.110 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 56 | 0.110 |
Why?
|
Lipopolysaccharides | 6 | 2020 | 2216 | 0.110 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1107 | 0.110 |
Why?
|
Animals, Laboratory | 1 | 2012 | 51 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 893 | 0.110 |
Why?
|
Arteries | 1 | 2017 | 1119 | 0.110 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2013 | 611 | 0.110 |
Why?
|
Carotid Artery Thrombosis | 1 | 2012 | 53 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2018 | 516 | 0.110 |
Why?
|
Exosomes | 1 | 2017 | 417 | 0.110 |
Why?
|
Protein Conformation | 1 | 2020 | 4011 | 0.110 |
Why?
|
Neoplasm Transplantation | 3 | 2019 | 2085 | 0.110 |
Why?
|
Somatosensory Disorders | 1 | 2012 | 47 | 0.110 |
Why?
|
Aspartate Aminotransferases | 1 | 2014 | 418 | 0.110 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 544 | 0.110 |
Why?
|
Diterpenes | 1 | 2013 | 173 | 0.110 |
Why?
|
Cell Line | 8 | 2023 | 15997 | 0.110 |
Why?
|
Taste | 1 | 2013 | 176 | 0.110 |
Why?
|
Swine Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
Type C Phospholipases | 1 | 2013 | 292 | 0.100 |
Why?
|
Dermis | 1 | 2013 | 207 | 0.100 |
Why?
|
Tumor Escape | 2 | 2017 | 349 | 0.100 |
Why?
|
Antipyretics | 1 | 2012 | 23 | 0.100 |
Why?
|
Transgenes | 2 | 2014 | 1009 | 0.100 |
Why?
|
Genetic Engineering | 4 | 2012 | 951 | 0.100 |
Why?
|
Macaca fascicularis | 5 | 2014 | 915 | 0.100 |
Why?
|
Tyrosine | 2 | 2012 | 1461 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2019 | 8428 | 0.100 |
Why?
|
Creatinine | 4 | 2013 | 1919 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 5 | 2008 | 1723 | 0.100 |
Why?
|
Complement Inactivating Agents | 1 | 2012 | 50 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2020 | 3768 | 0.100 |
Why?
|
Adenylate Kinase | 1 | 2012 | 100 | 0.100 |
Why?
|
Phosphoproteins | 2 | 2013 | 2440 | 0.100 |
Why?
|
Hair Cells, Vestibular | 1 | 2012 | 47 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 3 | 2003 | 424 | 0.100 |
Why?
|
Connexin 43 | 2 | 2017 | 207 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2014 | 835 | 0.100 |
Why?
|
Transplantation Tolerance | 4 | 2011 | 617 | 0.100 |
Why?
|
Transcription, Genetic | 6 | 2013 | 7722 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.100 |
Why?
|
DNA, Viral | 2 | 2017 | 2225 | 0.100 |
Why?
|
Mutation | 5 | 2022 | 29786 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1121 | 0.100 |
Why?
|
Hep G2 Cells | 3 | 2019 | 393 | 0.100 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2011 | 68 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5853 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 944 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.100 |
Why?
|
Glycolysis | 2 | 2013 | 827 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 957 | 0.100 |
Why?
|
Synaptic Transmission | 1 | 2017 | 1178 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2013 | 464 | 0.100 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2010 | 68 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1581 | 0.100 |
Why?
|
Heme Oxygenase-1 | 4 | 2007 | 381 | 0.100 |
Why?
|
Cell Hypoxia | 3 | 2018 | 675 | 0.100 |
Why?
|
Oxazolone | 1 | 2010 | 60 | 0.100 |
Why?
|
Ligation | 2 | 2009 | 453 | 0.100 |
Why?
|
Myocardial Ischemia | 2 | 2020 | 2148 | 0.100 |
Why?
|
Tungsten Compounds | 1 | 2010 | 10 | 0.100 |
Why?
|
Phenotype | 6 | 2022 | 16365 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2000 | 3420 | 0.090 |
Why?
|
Immunoglobulins | 2 | 2014 | 881 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 413 | 0.090 |
Why?
|
Lymphopenia | 1 | 2013 | 285 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.090 |
Why?
|
Hemostasis | 3 | 2013 | 458 | 0.090 |
Why?
|
Mitosis | 1 | 1996 | 1208 | 0.090 |
Why?
|
Aged | 17 | 2021 | 163280 | 0.090 |
Why?
|
Eye | 1 | 2014 | 729 | 0.090 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2010 | 226 | 0.090 |
Why?
|
Proteinuria | 1 | 2013 | 658 | 0.090 |
Why?
|
Blood Glucose | 3 | 2021 | 6256 | 0.090 |
Why?
|
Radiation Chimera | 1 | 2010 | 223 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 17446 | 0.090 |
Why?
|
Phagocytosis | 2 | 2012 | 1539 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2749 | 0.090 |
Why?
|
Corneal Transplantation | 1 | 2014 | 386 | 0.090 |
Why?
|
Aldosterone | 1 | 2015 | 877 | 0.090 |
Why?
|
Immunoglobulin M | 4 | 2022 | 1537 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4851 | 0.090 |
Why?
|
Antithrombin III | 2 | 2002 | 128 | 0.090 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 2 | 2009 | 250 | 0.090 |
Why?
|
Kidney Tubules | 2 | 2012 | 488 | 0.090 |
Why?
|
Immunoglobulin G | 5 | 2022 | 4560 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 592 | 0.090 |
Why?
|
Neurons | 5 | 2020 | 9338 | 0.090 |
Why?
|
Primates | 5 | 2013 | 545 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2010 | 1369 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9239 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13695 | 0.090 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1526 | 0.090 |
Why?
|
Cell Death | 2 | 2013 | 1706 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 11725 | 0.090 |
Why?
|
Pyridines | 2 | 2019 | 2825 | 0.090 |
Why?
|
Portal Pressure | 1 | 2009 | 62 | 0.090 |
Why?
|
Immunotherapy | 2 | 2017 | 4445 | 0.090 |
Why?
|
Amino Acid Sequence | 7 | 2008 | 13815 | 0.090 |
Why?
|
Autoimmunity | 2 | 2016 | 1349 | 0.090 |
Why?
|
Macrophages, Peritoneal | 1 | 2010 | 251 | 0.080 |
Why?
|
Hemorrhage | 4 | 2014 | 3461 | 0.080 |
Why?
|
Isoenzymes | 4 | 2006 | 1726 | 0.080 |
Why?
|
Adipose Tissue, Brown | 2 | 2021 | 757 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1940 | 0.080 |
Why?
|
Lung Injury | 2 | 2011 | 436 | 0.080 |
Why?
|
Hematologic Diseases | 1 | 2012 | 498 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1905 | 0.080 |
Why?
|
Cell Differentiation | 7 | 2021 | 11483 | 0.080 |
Why?
|
Microchemistry | 1 | 2008 | 57 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.080 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2009 | 136 | 0.080 |
Why?
|
Neutrophil Activation | 2 | 2006 | 186 | 0.080 |
Why?
|
Escherichia coli Infections | 1 | 2012 | 532 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9438 | 0.080 |
Why?
|
Cloning, Molecular | 3 | 2008 | 4320 | 0.080 |
Why?
|
Metalloproteases | 1 | 2008 | 62 | 0.080 |
Why?
|
Whole-Body Irradiation | 3 | 2012 | 449 | 0.080 |
Why?
|
Ischemia | 3 | 2012 | 1907 | 0.080 |
Why?
|
Blood | 2 | 2004 | 598 | 0.080 |
Why?
|
Blood Coagulation Factors | 3 | 2021 | 355 | 0.080 |
Why?
|
Edema | 1 | 2012 | 789 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2289 | 0.080 |
Why?
|
Sp1 Transcription Factor | 1 | 2008 | 144 | 0.080 |
Why?
|
Legionella pneumophila | 1 | 2008 | 46 | 0.080 |
Why?
|
Cholesterol | 1 | 2017 | 2917 | 0.080 |
Why?
|
Ristocetin | 3 | 2010 | 26 | 0.080 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 266 | 0.080 |
Why?
|
Kidney Glomerulus | 2 | 2008 | 697 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2023 | 768 | 0.080 |
Why?
|
Calcium | 6 | 2020 | 5756 | 0.080 |
Why?
|
Uridine | 2 | 2023 | 146 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2015 | 851 | 0.080 |
Why?
|
Enzyme Activation | 4 | 2008 | 3701 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2002 | 1155 | 0.080 |
Why?
|
Secretory Vesicles | 1 | 2008 | 124 | 0.080 |
Why?
|
Pregnancy Proteins | 1 | 2008 | 229 | 0.080 |
Why?
|
Auditory Threshold | 1 | 2009 | 364 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.080 |
Why?
|
Thromboembolism | 2 | 2006 | 986 | 0.070 |
Why?
|
Interleukin-1beta | 4 | 2017 | 972 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2008 | 1222 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2400 | 0.070 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2009 | 145 | 0.070 |
Why?
|
Glomerular Mesangium | 1 | 2007 | 108 | 0.070 |
Why?
|
Mice, Inbred CBA | 2 | 2005 | 448 | 0.070 |
Why?
|
DNA Transposable Elements | 1 | 2011 | 748 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1814 | 0.070 |
Why?
|
Streptozocin | 1 | 2007 | 196 | 0.070 |
Why?
|
Tissue Donors | 4 | 2012 | 2240 | 0.070 |
Why?
|
Antigens, Heterophile | 2 | 1998 | 69 | 0.070 |
Why?
|
Phosphorylation | 5 | 2013 | 8436 | 0.070 |
Why?
|
In Situ Hybridization | 3 | 2008 | 1950 | 0.070 |
Why?
|
Integrin alphaVbeta3 | 1 | 2007 | 111 | 0.070 |
Why?
|
Gene Transfer Techniques | 3 | 2001 | 1224 | 0.070 |
Why?
|
Species Specificity | 2 | 2010 | 2478 | 0.070 |
Why?
|
Brain | 5 | 2016 | 26385 | 0.070 |
Why?
|
Models, Biological | 8 | 2019 | 9583 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2008 | 431 | 0.070 |
Why?
|
Postoperative Complications | 5 | 2014 | 15295 | 0.070 |
Why?
|
Epitopes | 5 | 2005 | 2571 | 0.070 |
Why?
|
Protein Binding | 5 | 2018 | 9386 | 0.070 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 452 | 0.070 |
Why?
|
Interleukin-10 | 3 | 2022 | 1200 | 0.070 |
Why?
|
Adiponectin | 1 | 2012 | 1100 | 0.070 |
Why?
|
Protein Structure, Tertiary | 4 | 2006 | 3846 | 0.070 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 563 | 0.070 |
Why?
|
Hippocampus | 2 | 2017 | 3675 | 0.070 |
Why?
|
Repressor Proteins | 2 | 2023 | 3023 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2012 | 1366 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3703 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2008 | 905 | 0.070 |
Why?
|
Renin | 1 | 2008 | 642 | 0.070 |
Why?
|
Plasma Substitutes | 1 | 2005 | 57 | 0.070 |
Why?
|
Water | 1 | 2012 | 1395 | 0.070 |
Why?
|
Sequence Alignment | 3 | 2008 | 2256 | 0.070 |
Why?
|
Microscopy, Electron | 2 | 2000 | 2645 | 0.070 |
Why?
|
Fibrinolysis | 2 | 2014 | 322 | 0.070 |
Why?
|
Oncogene Proteins | 1 | 2010 | 749 | 0.070 |
Why?
|
Transcription Factors | 2 | 2012 | 12208 | 0.070 |
Why?
|
Immunity, Humoral | 1 | 2010 | 598 | 0.070 |
Why?
|
Young Adult | 9 | 2020 | 56430 | 0.070 |
Why?
|
Biliverdine | 1 | 2005 | 29 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2006 | 2050 | 0.070 |
Why?
|
Glioma | 2 | 2011 | 3401 | 0.070 |
Why?
|
Sirolimus | 1 | 2013 | 1564 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2018 | 743 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4034 | 0.060 |
Why?
|
Remission Induction | 3 | 2016 | 2386 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.060 |
Why?
|
RNA Probes | 1 | 2005 | 113 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3143 | 0.060 |
Why?
|
Hyperinsulinism | 1 | 2008 | 415 | 0.060 |
Why?
|
Interleukin-12 | 3 | 2014 | 579 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2016 | 1655 | 0.060 |
Why?
|
Drug Synergism | 4 | 2003 | 1792 | 0.060 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2005 | 120 | 0.060 |
Why?
|
Cyclic AMP | 2 | 2011 | 1472 | 0.060 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 326 | 0.060 |
Why?
|
Mice, Nude | 4 | 2016 | 3689 | 0.060 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 495 | 0.060 |
Why?
|
Chemokines | 2 | 2022 | 970 | 0.060 |
Why?
|
Antibody Specificity | 2 | 2005 | 1095 | 0.060 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 898 | 0.060 |
Why?
|
Multipotent Stem Cells | 1 | 2006 | 186 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
PPAR alpha | 1 | 2006 | 197 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 182 | 0.060 |
Why?
|
Prognosis | 8 | 2018 | 29063 | 0.060 |
Why?
|
Muscle, Smooth | 2 | 2019 | 934 | 0.060 |
Why?
|
Dipyridamole | 2 | 2003 | 145 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8863 | 0.060 |
Why?
|
Submandibular Gland | 1 | 2004 | 86 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1343 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1915 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2356 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2503 | 0.060 |
Why?
|
Caveolins | 1 | 2004 | 104 | 0.060 |
Why?
|
Ligands | 2 | 2022 | 3282 | 0.060 |
Why?
|
Dentate Gyrus | 1 | 2005 | 160 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39050 | 0.060 |
Why?
|
Organ Transplantation | 2 | 2007 | 1139 | 0.060 |
Why?
|
Oxygen Consumption | 2 | 2008 | 1869 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4838 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.060 |
Why?
|
Serum Albumin | 1 | 2007 | 676 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3481 | 0.060 |
Why?
|
Hematopoietic System | 1 | 2004 | 109 | 0.060 |
Why?
|
Pneumonia | 1 | 2015 | 2133 | 0.060 |
Why?
|
Retina | 1 | 2014 | 2616 | 0.060 |
Why?
|
Cholinergic Agents | 1 | 2024 | 93 | 0.060 |
Why?
|
Splenectomy | 2 | 2002 | 395 | 0.060 |
Why?
|
Microscopy, Video | 1 | 2004 | 245 | 0.060 |
Why?
|
Hemopexin | 1 | 2023 | 33 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2018 | 687 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2861 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2017 | 10943 | 0.060 |
Why?
|
Hydrocarbons | 1 | 2023 | 106 | 0.060 |
Why?
|
Ion Channels | 1 | 2008 | 1056 | 0.060 |
Why?
|
Aortic Valve | 2 | 2023 | 1922 | 0.060 |
Why?
|
Protein Kinases | 2 | 2007 | 1640 | 0.060 |
Why?
|
Phosphoglycerate Kinase | 1 | 2022 | 68 | 0.050 |
Why?
|
Insulin | 3 | 2021 | 6580 | 0.050 |
Why?
|
Endoscopy | 1 | 2013 | 1785 | 0.050 |
Why?
|
Salivary Glands | 1 | 2004 | 229 | 0.050 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2022 | 52 | 0.050 |
Why?
|
Cell Survival | 4 | 2013 | 5882 | 0.050 |
Why?
|
Rabbits | 3 | 2005 | 4894 | 0.050 |
Why?
|
Oligopeptides | 2 | 1999 | 1189 | 0.050 |
Why?
|
Peripheral Nervous System | 1 | 2004 | 150 | 0.050 |
Why?
|
Ferric Compounds | 2 | 2016 | 374 | 0.050 |
Why?
|
Cyclosporine | 3 | 2012 | 786 | 0.050 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 65 | 0.050 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 2000 | 307 | 0.050 |
Why?
|
Chimera | 1 | 2004 | 485 | 0.050 |
Why?
|
CHO Cells | 3 | 2017 | 1406 | 0.050 |
Why?
|
Dysarthria | 1 | 2022 | 57 | 0.050 |
Why?
|
Benzene | 1 | 2022 | 100 | 0.050 |
Why?
|
C-Reactive Protein | 4 | 2015 | 3778 | 0.050 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2004 | 964 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2003 | 438 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2006 | 627 | 0.050 |
Why?
|
Doxorubicin | 2 | 2023 | 2234 | 0.050 |
Why?
|
Cytoskeleton | 2 | 2005 | 1185 | 0.050 |
Why?
|
Chemokine CCL2 | 2 | 2001 | 617 | 0.050 |
Why?
|
Permeability | 1 | 2004 | 738 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2005 | 369 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2008 | 996 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5751 | 0.050 |
Why?
|
Chlorides | 2 | 2016 | 667 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Paraplegia | 1 | 2022 | 168 | 0.050 |
Why?
|
Genotype | 2 | 2009 | 12951 | 0.050 |
Why?
|
Langerhans Cells | 1 | 2002 | 173 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9648 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2915 | 0.050 |
Why?
|
Integrin beta3 | 1 | 2001 | 122 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 63114 | 0.050 |
Why?
|
Disulfides | 1 | 2003 | 457 | 0.050 |
Why?
|
Cricetinae | 5 | 2005 | 2472 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2022 | 272 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1620 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2017 | 5708 | 0.050 |
Why?
|
Receptor, Adenosine A1 | 1 | 2020 | 44 | 0.050 |
Why?
|
Thromboxane A2 | 1 | 2000 | 92 | 0.050 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2020 | 33 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2001 | 188 | 0.050 |
Why?
|
Dipeptides | 1 | 2003 | 409 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3047 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3920 | 0.050 |
Why?
|
Cell Adhesion Molecules | 2 | 2018 | 1602 | 0.050 |
Why?
|
Prospective Studies | 8 | 2017 | 53288 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.050 |
Why?
|
Weibel-Palade Bodies | 1 | 2000 | 19 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2001 | 334 | 0.050 |
Why?
|
Capillaries | 1 | 2004 | 773 | 0.050 |
Why?
|
Peroxidase | 1 | 2004 | 611 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2021 | 251 | 0.050 |
Why?
|
Myeloablative Agonists | 1 | 2021 | 218 | 0.050 |
Why?
|
Aspartic Acid | 1 | 2003 | 576 | 0.050 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 59 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2013 | 5021 | 0.050 |
Why?
|
Bile Canaliculi | 1 | 2000 | 11 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2022 | 758 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2021 | 336 | 0.050 |
Why?
|
Culture Media, Serum-Free | 1 | 2000 | 158 | 0.050 |
Why?
|
Endothelium | 2 | 2002 | 778 | 0.050 |
Why?
|
Guanosine Diphosphate | 2 | 2012 | 85 | 0.050 |
Why?
|
Cerebral Ventricles | 1 | 2003 | 544 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6314 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1596 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1364 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2009 | 2132 | 0.050 |
Why?
|
Promoter Regions, Genetic | 4 | 2014 | 5867 | 0.050 |
Why?
|
Perfusion | 2 | 2013 | 1360 | 0.050 |
Why?
|
Cognition | 1 | 2017 | 6770 | 0.050 |
Why?
|
Cathelicidins | 1 | 2020 | 80 | 0.050 |
Why?
|
Chromatography, Thin Layer | 1 | 2000 | 223 | 0.050 |
Why?
|
Suramin | 2 | 2015 | 34 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2013 | 2758 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2018 | 3505 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 1801 | 0.040 |
Why?
|
Tissue Distribution | 3 | 2002 | 2327 | 0.040 |
Why?
|
Stem Cell Factor | 1 | 2000 | 219 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1678 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2006 | 1352 | 0.040 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 131 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 3 | 2011 | 1990 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2008 | 1477 | 0.040 |
Why?
|
Plant Extracts | 1 | 2003 | 471 | 0.040 |
Why?
|
Fatty Acids | 1 | 2008 | 1809 | 0.040 |
Why?
|
Epoprostenol | 1 | 2000 | 254 | 0.040 |
Why?
|
Glycine | 1 | 2003 | 671 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 192 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1999 | 203 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2005 | 1117 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 707 | 0.040 |
Why?
|
Vasodilation | 1 | 2023 | 944 | 0.040 |
Why?
|
Erythrocyte Membrane | 1 | 2001 | 442 | 0.040 |
Why?
|
Interleukin-3 | 1 | 2000 | 444 | 0.040 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 2018 | 38 | 0.040 |
Why?
|
Feces | 2 | 2016 | 1401 | 0.040 |
Why?
|
Microscopy, Confocal | 3 | 2012 | 1970 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2001 | 526 | 0.040 |
Why?
|
Membrane Microdomains | 1 | 2020 | 203 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2021 | 611 | 0.040 |
Why?
|
Transcription Factor RelB | 1 | 1998 | 29 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1850 | 0.040 |
Why?
|
Cyclins | 2 | 2012 | 603 | 0.040 |
Why?
|
GTP Cyclohydrolase | 1 | 2018 | 46 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2000 | 537 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2000 | 243 | 0.040 |
Why?
|
Phospholipids | 1 | 2022 | 784 | 0.040 |
Why?
|
Homeodomain Proteins | 2 | 2022 | 2421 | 0.040 |
Why?
|
Urinary Bladder Diseases | 1 | 2019 | 166 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2003 | 732 | 0.040 |
Why?
|
Methyltransferases | 1 | 2021 | 367 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2000 | 371 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 8987 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.040 |
Why?
|
Endotoxemia | 1 | 2000 | 207 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12745 | 0.040 |
Why?
|
Coenzymes | 1 | 2018 | 91 | 0.040 |
Why?
|
Proteoglycans | 1 | 2001 | 835 | 0.040 |
Why?
|
Benzylamines | 2 | 1996 | 223 | 0.040 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1978 | 0.040 |
Why?
|
Erythrocyte Transfusion | 1 | 2023 | 565 | 0.040 |
Why?
|
Organ Specificity | 2 | 2019 | 2008 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 664 | 0.040 |
Why?
|
Binding Sites | 3 | 2012 | 6114 | 0.040 |
Why?
|
Complement C3d | 1 | 2017 | 21 | 0.040 |
Why?
|
Adipose Tissue, White | 1 | 2021 | 351 | 0.040 |
Why?
|
Alcohol Oxidoreductases | 1 | 2018 | 170 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 3 | 2011 | 2505 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2020 | 625 | 0.040 |
Why?
|
ROC Curve | 2 | 2016 | 3527 | 0.040 |
Why?
|
Proteins | 3 | 2013 | 6103 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2866 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 320 | 0.040 |
Why?
|
Partial Pressure | 1 | 2017 | 254 | 0.040 |
Why?
|
Bacteria | 1 | 2008 | 2114 | 0.040 |
Why?
|
Hemostatics | 1 | 2000 | 229 | 0.040 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2017 | 23 | 0.040 |
Why?
|
Hypertension | 1 | 2017 | 8480 | 0.040 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2017 | 74 | 0.040 |
Why?
|
Chromosome Fragile Sites | 1 | 2017 | 27 | 0.040 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2017 | 27 | 0.040 |
Why?
|
Cytoplasmic Granules | 1 | 2020 | 610 | 0.040 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2001 | 560 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2000 | 648 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 2017 | 142 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 1999 | 433 | 0.040 |
Why?
|
Superoxides | 1 | 1998 | 387 | 0.040 |
Why?
|
Lymphokines | 1 | 2020 | 949 | 0.040 |
Why?
|
Serotonin | 1 | 2001 | 1017 | 0.040 |
Why?
|
Angioplasty, Balloon | 1 | 2001 | 653 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4931 | 0.040 |
Why?
|
Injections, Intra-Arterial | 1 | 1996 | 193 | 0.040 |
Why?
|
Femoral Artery | 1 | 2001 | 845 | 0.040 |
Why?
|
Immunoblotting | 1 | 2020 | 1682 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2008 | 2899 | 0.040 |
Why?
|
Chronic Disease | 2 | 2015 | 9146 | 0.040 |
Why?
|
Antigen Presentation | 2 | 2013 | 1284 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2021 | 759 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2017 | 270 | 0.040 |
Why?
|
Kidney Function Tests | 2 | 2010 | 684 | 0.040 |
Why?
|
alpha-Defensins | 1 | 2016 | 28 | 0.040 |
Why?
|
Mucin-2 | 1 | 2016 | 49 | 0.040 |
Why?
|
Cytomegalovirus Infections | 1 | 2003 | 820 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 1998 | 426 | 0.040 |
Why?
|
Ritonavir | 1 | 2018 | 322 | 0.040 |
Why?
|
Molecular Weight | 1 | 1999 | 2255 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14722 | 0.040 |
Why?
|
Factor VIIa | 1 | 1997 | 101 | 0.040 |
Why?
|
Antibody Affinity | 1 | 2017 | 254 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1996 | 377 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 2007 | 0.030 |
Why?
|
Disease Progression | 3 | 2019 | 13284 | 0.030 |
Why?
|
Catalase | 1 | 2016 | 222 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 2942 | 0.030 |
Why?
|
Membrane Potentials | 2 | 2011 | 1137 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2012 | 11031 | 0.030 |
Why?
|
Spumavirus | 1 | 2015 | 16 | 0.030 |
Why?
|
Hybridomas | 1 | 2017 | 452 | 0.030 |
Why?
|
Calgranulin B | 1 | 2016 | 84 | 0.030 |
Why?
|
Antigens | 1 | 2001 | 1466 | 0.030 |
Why?
|
Chemokine CXCL2 | 1 | 2015 | 111 | 0.030 |
Why?
|
Arenaviridae Infections | 1 | 2015 | 51 | 0.030 |
Why?
|
Alcoholism | 1 | 2006 | 1906 | 0.030 |
Why?
|
Mutagenesis | 1 | 2000 | 1266 | 0.030 |
Why?
|
Retroviridae | 1 | 1998 | 914 | 0.030 |
Why?
|
Receptors, Adenosine A2 | 1 | 2015 | 14 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4397 | 0.030 |
Why?
|
Cattle | 2 | 1998 | 3922 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2916 | 0.030 |
Why?
|
Factor VII | 1 | 2015 | 139 | 0.030 |
Why?
|
Antibodies, Blocking | 1 | 1996 | 253 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13102 | 0.030 |
Why?
|
Animals, Newborn | 3 | 2008 | 2726 | 0.030 |
Why?
|
Fibrinogen | 1 | 1998 | 894 | 0.030 |
Why?
|
Cell Membrane Permeability | 2 | 2010 | 590 | 0.030 |
Why?
|
Cricetulus | 1 | 2017 | 816 | 0.030 |
Why?
|
Coronary Circulation | 2 | 2014 | 1572 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1997 | 1581 | 0.030 |
Why?
|
Immunization, Passive | 1 | 2017 | 623 | 0.030 |
Why?
|
Cytoplasm | 1 | 2000 | 1539 | 0.030 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2015 | 132 | 0.030 |
Why?
|
Down-Regulation | 2 | 2016 | 3002 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1224 | 0.030 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2015 | 168 | 0.030 |
Why?
|
Morganella morganii | 1 | 2014 | 3 | 0.030 |
Why?
|
Donor Selection | 1 | 2016 | 201 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2020 | 1585 | 0.030 |
Why?
|
Streptomycin | 1 | 2014 | 69 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2454 | 0.030 |
Why?
|
Deoxyribonucleotides | 1 | 2014 | 42 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 224 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12959 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 1997 | 634 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8664 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2016 | 712 | 0.030 |
Why?
|
Pedigree | 1 | 2022 | 4644 | 0.030 |
Why?
|
Genes, Reporter | 1 | 1998 | 1547 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2020 | 1221 | 0.030 |
Why?
|
Ampicillin | 1 | 2014 | 139 | 0.030 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2013 | 46 | 0.030 |
Why?
|
Chorda Tympani Nerve | 1 | 2013 | 15 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1660 | 0.030 |
Why?
|
Collagen | 1 | 2022 | 2689 | 0.030 |
Why?
|
Cold Ischemia | 1 | 2014 | 65 | 0.030 |
Why?
|
Glossopharyngeal Nerve | 1 | 2013 | 18 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 964 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 597 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3616 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1783 | 0.030 |
Why?
|
Starvation | 1 | 2014 | 134 | 0.030 |
Why?
|
Enzyme Induction | 2 | 2007 | 475 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 72290 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1998 | 1663 | 0.030 |
Why?
|
Estrenes | 1 | 2013 | 23 | 0.030 |
Why?
|
Epidermis | 1 | 2016 | 528 | 0.030 |
Why?
|
Insulin-Secreting Cells | 1 | 2021 | 891 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2015 | 287 | 0.030 |
Why?
|
Heparin | 1 | 2000 | 1637 | 0.030 |
Why?
|
Fucosyltransferases | 1 | 2013 | 119 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 2376 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2008 | 5172 | 0.030 |
Why?
|
Platelet Count | 2 | 2006 | 781 | 0.030 |
Why?
|
Action Potentials | 1 | 2020 | 1806 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2012 | 32 | 0.030 |
Why?
|
Receptors, GABA-A | 1 | 2017 | 627 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 1708 | 0.030 |
Why?
|
Inosine | 1 | 2013 | 133 | 0.030 |
Why?
|
Leukapheresis | 1 | 2012 | 131 | 0.030 |
Why?
|
Water Deprivation | 1 | 2012 | 21 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2012 | 29 | 0.030 |
Why?
|
Renal Agents | 1 | 2012 | 32 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3282 | 0.030 |
Why?
|
Kidney Concentrating Ability | 1 | 2012 | 41 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2013 | 224 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 2013 | 261 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2001 | 1889 | 0.030 |
Why?
|
Bleomycin | 1 | 2013 | 512 | 0.030 |
Why?
|
Enterococcus faecalis | 1 | 2014 | 251 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 386 | 0.030 |
Why?
|
Receptors, Purinergic P2Y | 1 | 2012 | 25 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 2013 | 117 | 0.030 |
Why?
|
Phenylalanine | 1 | 2014 | 365 | 0.030 |
Why?
|
Ventricular Function, Left | 2 | 2020 | 3670 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.030 |
Why?
|
Suppressor Factors, Immunologic | 1 | 2012 | 68 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 494 | 0.030 |
Why?
|
Complement Pathway, Classical | 1 | 2012 | 97 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 2013 | 245 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6365 | 0.030 |
Why?
|
Immunotoxins | 1 | 2012 | 179 | 0.030 |
Why?
|
Hydrolases | 1 | 2013 | 139 | 0.030 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2012 | 91 | 0.030 |
Why?
|
Troponin I | 2 | 2007 | 619 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2012 | 205 | 0.030 |
Why?
|
Escherichia coli | 2 | 2014 | 4217 | 0.030 |
Why?
|
Adolescent | 6 | 2017 | 85781 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2001 | 1177 | 0.030 |
Why?
|
Particle Size | 1 | 2016 | 1642 | 0.030 |
Why?
|
Hematocrit | 2 | 2003 | 636 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3567 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1152 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 783 | 0.030 |
Why?
|
Macrophage-1 Antigen | 1 | 2012 | 290 | 0.030 |
Why?
|
Symbiosis | 1 | 2014 | 287 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1572 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2017 | 1462 | 0.030 |
Why?
|
Vascular Patency | 1 | 2014 | 886 | 0.030 |
Why?
|
Mucin-1 | 1 | 2016 | 543 | 0.030 |
Why?
|
Survival Rate | 2 | 2016 | 12788 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2012 | 399 | 0.020 |
Why?
|
Uridine Monophosphate | 1 | 2012 | 70 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.020 |
Why?
|
Blood Pressure | 3 | 2015 | 8554 | 0.020 |
Why?
|
Cytoprotection | 1 | 2012 | 210 | 0.020 |
Why?
|
Mesocricetus | 2 | 2002 | 252 | 0.020 |
Why?
|
Informed Consent | 1 | 1998 | 995 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1654 | 0.020 |
Why?
|
Pregnancy | 4 | 2019 | 29144 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 140 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2000 | 2969 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 683 | 0.020 |
Why?
|
Drinking | 1 | 2012 | 197 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1996 | 2187 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
Health Education | 1 | 1998 | 1056 | 0.020 |
Why?
|
Survival Analysis | 2 | 2016 | 10252 | 0.020 |
Why?
|
Drug Interactions | 2 | 2008 | 1460 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2018 | 57776 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2014 | 669 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 25043 | 0.020 |
Why?
|
Myocardial Reperfusion | 1 | 2012 | 351 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2000 | 2731 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2013 | 936 | 0.020 |
Why?
|
Infection Control | 1 | 1998 | 966 | 0.020 |
Why?
|
Insulinoma | 1 | 2011 | 124 | 0.020 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2011 | 154 | 0.020 |
Why?
|
Antioxidants | 1 | 1998 | 1663 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2012 | 813 | 0.020 |
Why?
|
Iron | 1 | 2018 | 1774 | 0.020 |
Why?
|
Thrombotic Microangiopathies | 1 | 2011 | 132 | 0.020 |
Why?
|
Granulocytes | 1 | 2012 | 548 | 0.020 |
Why?
|
Etoposide | 1 | 2011 | 641 | 0.020 |
Why?
|
Organ of Corti | 1 | 2010 | 84 | 0.020 |
Why?
|
Exoribonucleases | 1 | 2010 | 95 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 190 | 0.020 |
Why?
|
Anti-Bacterial Agents | 3 | 2012 | 7181 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 588 | 0.020 |
Why?
|
Smad Proteins | 1 | 2010 | 162 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 692 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 320 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2009 | 96 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2018 | 1102 | 0.020 |
Why?
|
Sodium | 1 | 2015 | 1623 | 0.020 |
Why?
|
Ribonucleases | 1 | 2010 | 287 | 0.020 |
Why?
|
Quinacrine | 2 | 1999 | 24 | 0.020 |
Why?
|
Cations | 1 | 2010 | 232 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2013 | 652 | 0.020 |
Why?
|
Nucleosides | 1 | 2010 | 138 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2013 | 822 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3912 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2014 | 1767 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2012 | 538 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 578 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
Cell Division | 2 | 2008 | 4568 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2010 | 791 | 0.020 |
Why?
|
Spiral Ganglion | 1 | 2010 | 169 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1996 | 1904 | 0.020 |
Why?
|
Ticlopidine | 1 | 2014 | 899 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2014 | 1074 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4740 | 0.020 |
Why?
|
Heart Rate | 2 | 2012 | 4091 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2012 | 1588 | 0.020 |
Why?
|
Colonoscopy | 1 | 2016 | 1367 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2013 | 726 | 0.020 |
Why?
|
Neurogenesis | 1 | 2015 | 838 | 0.020 |
Why?
|
NAD | 1 | 2012 | 593 | 0.020 |
Why?
|
Cytidine | 1 | 2008 | 68 | 0.020 |
Why?
|
Killer Cells, Lymphokine-Activated | 1 | 2007 | 42 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2014 | 1261 | 0.020 |
Why?
|
Ascites | 1 | 2010 | 344 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2008 | 365 | 0.020 |
Why?
|
Facial Nerve Diseases | 1 | 2008 | 50 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 21746 | 0.020 |
Why?
|
Adenosine-5'-(N-ethylcarboxamide) | 1 | 2007 | 15 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2362 | 0.020 |
Why?
|
Ureter | 2 | 2001 | 375 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 643 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2011 | 624 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Membrane Proteins | 3 | 2005 | 7880 | 0.020 |
Why?
|
Hair Cells, Auditory | 1 | 2010 | 361 | 0.020 |
Why?
|
Antibody Formation | 2 | 2002 | 1402 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1031 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6773 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2013 | 722 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2716 | 0.020 |
Why?
|
HT29 Cells | 1 | 2007 | 200 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 928 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2010 | 671 | 0.020 |
Why?
|
Coloring Agents | 1 | 2009 | 566 | 0.020 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 222 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1035 | 0.020 |
Why?
|
Tetrazoles | 1 | 2012 | 835 | 0.020 |
Why?
|
Entorhinal Cortex | 1 | 2008 | 272 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2009 | 853 | 0.020 |
Why?
|
Early Growth Response Protein 1 | 1 | 2006 | 140 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2008 | 494 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.020 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2006 | 71 | 0.020 |
Why?
|
Fetus | 2 | 2004 | 1880 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4554 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.020 |
Why?
|
Motor Activity | 1 | 2016 | 2714 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2015 | 2072 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 1941 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.020 |
Why?
|
Risk Assessment | 2 | 2016 | 23338 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2703 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2008 | 964 | 0.020 |
Why?
|
Consensus | 1 | 2014 | 2959 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1536 | 0.020 |
Why?
|
Dependovirus | 1 | 2010 | 706 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2252 | 0.020 |
Why?
|
Autoantibodies | 1 | 2013 | 2035 | 0.020 |
Why?
|
Child | 4 | 2016 | 77709 | 0.020 |
Why?
|
Cations, Divalent | 1 | 2005 | 166 | 0.020 |
Why?
|
Renal Artery | 1 | 2007 | 398 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2006 | 272 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.020 |
Why?
|
Protoporphyrins | 1 | 2005 | 164 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.020 |
Why?
|
Public Health | 1 | 1998 | 2603 | 0.020 |
Why?
|
United States | 4 | 2016 | 69872 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 1202 | 0.020 |
Why?
|
Satellite Cells, Perineuronal | 1 | 2004 | 2 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7913 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Ganglia | 1 | 2004 | 89 | 0.010 |
Why?
|
Sulfoxides | 1 | 2003 | 48 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6933 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12026 | 0.010 |
Why?
|
Garlic | 1 | 2003 | 29 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2006 | 1420 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2006 | 599 | 0.010 |
Why?
|
Crotalid Venoms | 1 | 2003 | 28 | 0.010 |
Why?
|
Metals | 1 | 2008 | 719 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 2003 | 55 | 0.010 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2003 | 40 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 2003 | 152 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2005 | 694 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2019 | 77449 | 0.010 |
Why?
|
Tenascin | 1 | 2003 | 59 | 0.010 |
Why?
|
Schwann Cells | 1 | 2004 | 195 | 0.010 |
Why?
|
Corticosterone | 1 | 2004 | 310 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 708 | 0.010 |
Why?
|
Hemagglutinins | 1 | 2003 | 117 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2003 | 427 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2250 | 0.010 |
Why?
|
Heart | 1 | 1996 | 4467 | 0.010 |
Why?
|
Liposomes | 1 | 2006 | 759 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5985 | 0.010 |
Why?
|
Vimentin | 1 | 2003 | 261 | 0.010 |
Why?
|
Irritants | 1 | 2002 | 44 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 2002 | 158 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8301 | 0.010 |
Why?
|
Leukocyte Transfusion | 1 | 2001 | 60 | 0.010 |
Why?
|
Thiazoles | 1 | 2009 | 1483 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Purinergic P2 Receptor Agonists | 1 | 2001 | 14 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2003 | 528 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Histamine | 1 | 2003 | 507 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2014 | 3297 | 0.010 |
Why?
|
Introns | 1 | 2004 | 991 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2002 | 573 | 0.010 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2002 | 295 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 1917 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2699 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
History, 17th Century | 1 | 2001 | 111 | 0.010 |
Why?
|
Collagen Type I | 1 | 2004 | 592 | 0.010 |
Why?
|
Random Allocation | 1 | 2005 | 2429 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 41006 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1641 | 0.010 |
Why?
|
Chromatography, Agarose | 1 | 2000 | 28 | 0.010 |
Why?
|
Cytosol | 1 | 2004 | 901 | 0.010 |
Why?
|
Sodium Azide | 1 | 2000 | 24 | 0.010 |
Why?
|
Thymus Gland | 1 | 2005 | 1267 | 0.010 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2000 | 56 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8089 | 0.010 |
Why?
|
Microsomes | 1 | 2000 | 257 | 0.010 |
Why?
|
Bleeding Time | 1 | 1999 | 89 | 0.010 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 1999 | 76 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2014 | 3079 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2004 | 1216 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3821 | 0.010 |
Why?
|
Molecular Probe Techniques | 1 | 1999 | 119 | 0.010 |
Why?
|
Thrombospondins | 1 | 1999 | 197 | 0.010 |
Why?
|
Protein Transport | 1 | 2005 | 1988 | 0.010 |
Why?
|
Mesentery | 1 | 1999 | 205 | 0.010 |
Why?
|
Arterioles | 1 | 1999 | 254 | 0.010 |
Why?
|
Amino Acids | 1 | 2005 | 1736 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2001 | 698 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2000 | 608 | 0.010 |
Why?
|
History, 19th Century | 1 | 2001 | 720 | 0.010 |
Why?
|
Saphenous Vein | 1 | 2001 | 532 | 0.010 |
Why?
|
RNA Interference | 1 | 2007 | 2889 | 0.010 |
Why?
|
Genistein | 1 | 1998 | 88 | 0.010 |
Why?
|
Exons | 1 | 2004 | 2437 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15540 | 0.010 |
Why?
|
Animal Experimentation | 1 | 1998 | 45 | 0.010 |
Why?
|
Ethics | 1 | 1998 | 94 | 0.010 |
Why?
|
Glycoconjugates | 1 | 1998 | 87 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1998 | 414 | 0.010 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 437 | 0.010 |
Why?
|
Hemoglobins | 1 | 2003 | 1534 | 0.010 |
Why?
|
Intercellular Junctions | 1 | 1998 | 203 | 0.010 |
Why?
|
Point Mutation | 1 | 2003 | 1623 | 0.010 |
Why?
|
Social Control, Formal | 1 | 1998 | 110 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.010 |
Why?
|
Receptors, Thrombin | 1 | 1997 | 131 | 0.010 |
Why?
|
Haplorhini | 1 | 1998 | 552 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 1998 | 457 | 0.010 |
Why?
|
Fibrin | 1 | 1999 | 506 | 0.010 |
Why?
|
Phylogeny | 1 | 2004 | 2803 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 489 | 0.010 |
Why?
|
Lung Diseases | 1 | 2006 | 1886 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2009 | 3848 | 0.010 |
Why?
|
Megakaryocytes | 1 | 1999 | 545 | 0.010 |
Why?
|
Ethics, Medical | 1 | 2001 | 792 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12261 | 0.010 |
Why?
|
Directed Molecular Evolution | 1 | 1996 | 160 | 0.010 |
Why?
|
Solubility | 1 | 1996 | 1085 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8949 | 0.010 |
Why?
|
Stroke Volume | 1 | 2007 | 5007 | 0.010 |
Why?
|
Infant | 1 | 2016 | 35136 | 0.010 |
Why?
|
Complement C3 | 1 | 1996 | 461 | 0.010 |
Why?
|
Coculture Techniques | 1 | 1998 | 1341 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2008 | 3265 | 0.010 |
Why?
|
Advisory Committees | 1 | 1998 | 775 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4803 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25625 | 0.010 |
Why?
|
Uncertainty | 1 | 1998 | 734 | 0.010 |
Why?
|
History, 20th Century | 1 | 2001 | 2740 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 5456 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 1998 | 1405 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 6489 | 0.010 |
Why?
|
Actins | 1 | 1998 | 2121 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 1998 | 1584 | 0.010 |
Why?
|
HIV Infections | 1 | 2015 | 16718 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2005 | 5535 | 0.010 |
Why?
|
Age Factors | 1 | 2005 | 18370 | 0.000 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 1998 | 1390 | 0.000 |
Why?
|
Environmental Exposure | 1 | 2001 | 4234 | 0.000 |
Why?
|